Karl Egan

926 total citations
29 papers, 554 citations indexed

About

Karl Egan is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Karl Egan has authored 29 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 8 papers in Cardiology and Cardiovascular Medicine and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Karl Egan's work include Blood Coagulation and Thrombosis Mechanisms (9 papers), Pregnancy and preeclampsia studies (6 papers) and Venous Thromboembolism Diagnosis and Management (6 papers). Karl Egan is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (9 papers), Pregnancy and preeclampsia studies (6 papers) and Venous Thromboembolism Diagnosis and Management (6 papers). Karl Egan collaborates with scholars based in Ireland, United States and United Kingdom. Karl Egan's co-authors include Dermot Kenny, Fionnuala Ní Áinle, Barry Kevane, Patricia B. Maguire, Paulina B. Szklanna, Domenico Praticò, Garret A. FitzGerald, Yong Cheng, Shamly Austin and Kieran Wynne and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Analytical Chemistry.

In The Last Decade

Karl Egan

29 papers receiving 537 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karl Egan Ireland 15 194 159 116 96 85 29 554
V Deutsch Israel 11 104 0.5× 67 0.4× 81 0.7× 54 0.6× 85 1.0× 19 423
Rafael Perini Canada 11 144 0.7× 103 0.6× 89 0.8× 6 0.1× 143 1.7× 19 625
Tomasz Brzóska United States 15 175 0.9× 30 0.2× 254 2.2× 10 0.1× 120 1.4× 31 594
María Eugenia de la Morena‐Barrio Spain 16 458 2.4× 54 0.3× 259 2.2× 7 0.1× 49 0.6× 67 798
Meral Günaldı Türkiye 17 31 0.2× 280 1.8× 171 1.5× 17 0.2× 109 1.3× 56 639
F Thomas United States 12 54 0.3× 85 0.5× 251 2.2× 11 0.1× 65 0.8× 61 826
Katie Houck United States 12 133 0.7× 26 0.2× 156 1.3× 65 0.7× 31 0.4× 17 409
H. Ireland United Kingdom 21 677 3.5× 61 0.4× 148 1.3× 19 0.2× 162 1.9× 47 987
Yeon S. Ahn United States 9 239 1.2× 24 0.2× 153 1.3× 23 0.2× 72 0.8× 10 488
Sigrun Badrnya Austria 10 153 0.8× 90 0.6× 196 1.7× 5 0.1× 47 0.6× 16 593

Countries citing papers authored by Karl Egan

Since Specialization
Citations

This map shows the geographic impact of Karl Egan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Egan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Egan more than expected).

Fields of papers citing papers by Karl Egan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl Egan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Egan. The network helps show where Karl Egan may publish in the future.

Co-authorship network of co-authors of Karl Egan

This figure shows the co-authorship network connecting the top 25 collaborators of Karl Egan. A scholar is included among the top collaborators of Karl Egan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl Egan. Karl Egan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weiß, Luisa, Paulina B. Szklanna, Karl Egan, et al.. (2024). Proteomic analysis of extracellular vesicle cargoes mirror the cardioprotective effects of rivaroxaban in patients with venous thromboembolism. PROTEOMICS - CLINICAL APPLICATIONS. 18(4). e202300014–e202300014. 3 indexed citations
2.
Weiß, Luisa, John F. Keaney, Paulina B. Szklanna, et al.. (2021). Nonvalvular atrial fibrillation patients anticoagulated with rivaroxaban compared with warfarin exhibit reduced circulating extracellular vesicles with attenuated pro‐inflammatory protein signatures. Journal of Thrombosis and Haemostasis. 19(10). 2583–2595. 10 indexed citations
3.
Egan, Karl, Kiran Parmar, Tom McKinnon, et al.. (2019). Alterations in fibrin formation and fibrinolysis in early onset-preeclampsia: Association with disease severity. European Journal of Obstetrics & Gynecology and Reproductive Biology. 241. 19–23. 15 indexed citations
4.
Egan, Karl, Barry Kevane, Zita Galvin, et al.. (2019). Liver stiffness and thrombin generation in compensated cirrhosis. Research and Practice in Thrombosis and Haemostasis. 3(2). 291–297. 3 indexed citations
5.
Kevane, Barry, Kevin Walsh, Karl Egan, et al.. (2018). Dual endothelin‐1 receptor antagonism attenuates platelet‐mediated derangements of blood coagulation in Eisenmenger syndrome. Journal of Thrombosis and Haemostasis. 16(8). 1572–1579. 8 indexed citations
6.
Bradley, C.R., Peter Hoffman, Karl Egan, et al.. (2018). Guidance for the decontamination of intracavity medical devices: the report of a working group of the Healthcare Infection Society. Journal of Hospital Infection. 101(1). 1–10. 6 indexed citations
7.
Egan, Karl, Johanna P. van Geffen, Hui Ma, et al.. (2017). Effect of platelet-derived β-thromboglobulins on coagulation. Thrombosis Research. 154. 7–15. 9 indexed citations
8.
Kevane, Barry, et al.. (2017). Endothelial barrier protective properties of low molecular weight heparin: A novel potential tool in the prevention of cancer metastasis?. Research and Practice in Thrombosis and Haemostasis. 1(1). 23–32. 7 indexed citations
9.
Egan, Karl, Barry Kevane, Fergal D. Malone, et al.. (2017). Elevated plasma TFPI activity causes attenuated TF-dependent thrombin generation in early onset preeclampsia. Thrombosis and Haemostasis. 117(8). 1549–1557. 16 indexed citations
10.
Szklanna, Paulina B., Kieran Wynne, Marie T. Nolan, et al.. (2017). Comparative proteomic analysis of trophoblast cell models reveals their differential phenotypes, potential uses, and limitations. PROTEOMICS. 17(10). e1700037–e1700037. 17 indexed citations
11.
Egan, Karl, Eimear Dunne, Barry Kevane, et al.. (2016). Increased soluble GPVI levels in cirrhosis: evidence for early in vivo platelet activation. Journal of Thrombosis and Thrombolysis. 43(1). 54–59. 13 indexed citations
12.
Neary, Elaine, Naomi McCallion, Barry Kevane, et al.. (2015). Coagulation indices in very preterm infants from cord blood and postnatal samples. Journal of Thrombosis and Haemostasis. 13(11). 2021–2030. 45 indexed citations
13.
Egan, Karl, Barry Kevane, & Fionnuala Ní Áinle. (2015). Elevated venous thromboembolism risk in preeclampsia: molecular mechanisms and clinical impact. Biochemical Society Transactions. 43(4). 696–701. 29 indexed citations
14.
Egan, Karl, et al.. (2014). Living in shear: platelets protect cancer cells from shear induced damage. Clinical & Experimental Metastasis. 31(6). 697–704. 121 indexed citations
15.
16.
Egan, Karl, David P. Foley, Antonio J. Ricco, et al.. (2013). Individual Platelet Adhesion Assay: Measuring Platelet Function and Antiplatelet Therapies in Whole Blood via Digital Quantification of Cell Adhesion. Analytical Chemistry. 85(13). 6497–6504. 17 indexed citations
17.
Smith, S. M., Nancy L. Bartlett, Jeffrey L. Johnson, et al.. (2010). Galiximab, an anti-CD80 primatized monoclonal antibody, in relapsed Hodgkin lymphoma: Final results of CALGB 50602.. Journal of Clinical Oncology. 28(15_suppl). 8039–8039. 3 indexed citations
18.
McElroy, Jane A., Polly A. Newcomb, Amy Trentham‐Dietz, et al.. (2005). BREAST CANCER RISK ASSOCIATED WITH ELECTROMAGNETIC FIELD EXPOSURE FROM COMPUTER WORK ASCERTAINED FROM OCCUPATIONAL HISTORY DATA. Epidemiology. 16(5). S99–S100. 4 indexed citations
19.
FitzGerald, Garret A., Shamly Austin, Karl Egan, Yong Cheng, & Domenico Praticò. (2000). Cyclo-oxygenase products and atherothrombosis.. PubMed. 32 Suppl 1. 21–6. 44 indexed citations
20.
Lane, Anne Marie, Karl Egan, Jie Yang, et al.. (1997). An evaluation of tumour vascularity as a prognostic indicator in uveal melanoma. Melanoma Research. 7(3). 237–242. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by V Deutsch Breakdown of academic impact, for papers by Rafael Perini Breakdown of academic impact, for papers by Tomasz Brzóska Breakdown of academic impact, for papers by María Eugenia de la Morena‐Barrio Breakdown of academic impact, for papers by Meral Günaldı Breakdown of academic impact, for papers by F Thomas Breakdown of academic impact, for papers by Katie Houck Breakdown of academic impact, for papers by H. Ireland Breakdown of academic impact, for papers by Yeon S. Ahn Breakdown of academic impact, for papers by Sigrun Badrnya
Rankless by CCL
2026